Home / Generics

Generics

News

FDA approves lung cancer and anticoagulant generics posted 20/03/2020

The US Food and Drug Administration (FDA) has issued a final approval for a generic version of Alimta (pemetrexed) and two ne...

Chinese company makes copy of patented coronavirus treatment remdesivir posted 03/03/2020

China’s BrightGene has successfully produced remdesivir, an experimental treatment for coronavirus, however, patents for the...

EMA recommends four new generics posted 21/02/2020

At the Committee for Medicinal Products for Human Use’s (CHMP) January 2020 meeting, the Committee recommended four new gener...

FDA approves generics for cancer and gout posted 31/01/2020

The US Food and Drug Administration (FDA) has approved two generic versions of Novartis’ anticancer drug Afinitor (everolimus...

FDA approves MS and prostate generics posted 17/01/2020

The US Food and Drug Administration (FDA) in December 2019 approved the first generics of Gilenya (fingolimod) for multiple s...

 

Research

Generics outreach programmes should target high income groups posted 30/03/2020

Patients with lower incomes are more likely to use generic drugs, finds a literature review from Auburn University, Alabama,...

Pharmacopeial standards may increase generics competition posted 13/03/2020

Pharmacopeias, which contain descriptions of drug preparations, are critical for ensuring the safety of drug products. A stud...

Delayed entry of buprenorphine generics cost NHS England GBP 0.5 million posted 10/03/2020

A market analysis has shown that lack of competition for generic buprenorphinepatches meant the National Health Service (NHS)...

Survey reveals attitudes to unauthorized hepatitis C generics posted 28/02/2020

A survey of physicians, pharmacists, patients and other professionals in Switzerland has shown that, although most people thi...

Medicare Part D has no impact on generics prescribing in long-term care posted 17/01/2020

A recent observational study [1] in long-term care facilities in the US shows that the Medicare Part D programme has no signi...

 

General

US lawmakers question FDA on complex generics approvals posted 28/02/2020

A US Congress Committee have sent a letter to the US Food and Drug Administration (FDA) regarding concerns over the approval...

Russian drug shortages at ‘crisis point’ posted 25/02/2020

Russia has been facing limited access to foreign pharmaceutical products for several years, but recent reports suggest drug s...

Irish pharmaceutical association urges political parties to create a new medicines policy posted 14/02/2020

The Irish Pharmaceutical Healthcare Association (IPHA) has urged political parties to mandate new policy to increase access t...

Generics applications under review by EMA – January 2020 posted 07/02/2020

Generic medicines in Europe can be approved either centrally via the European Medicines Agency (EMA) or nationally via the lo...

FDA sets up centre to improve quality of compounded drugs posted 30/01/2020

The US Food and Drug Administration (FDA) has established a Center of Excellence to improve the quality of compounded drugs,...